Do You Live With Plantar Fibromatosis?

Consider enrolling in our EN3835-309 PFI STRIDE study!

Plantar fibromatosis (PFI) is a rare disease of the foot. In PFI, one or more slow-growing, benign (non-cancerous) lumps form along the bottom of the foot. The lump(s) enlarge and become swollen. Walking and even bearing weight on the affected foot can be painful.

Plantar fibromatosis (also known as Ledderhose disease) is a rare pathology of the plantar aponeurosis characterized by disordered fibrous tissue and the subsequent formation of nodules. The primary symptoms include one or more slow-growing benign lumps that form along the medial longitudinal arch which usually become painful and swollen. The condition may reduce quality of life and can cause functional disability, leading in some cases to severe impairment.

If you have PFI or are unsure and have symptoms that you may believe are PFI, please fill out the form on the right and our Clinical Research Coordinator will contact you to learn more and see if you are eligible to participate in this study.

REQUEST INFORMATION

Fill Out The Form To Speak To A Clinical Research Coordinator!

About EN3835-309 PFI STRIDE

EN3835-309 PFI STRIDE is a clinical study testing whether the investigational drug, EN3835, may be able to help with PFI associated pain.

After a 28-day screening period, approximately 418 eligible participants with PFI will enter the study. They will be randomized (like the flip of a coin) to receive injection of the investigational drug or placebo (treatment 1). The placebo looks the same as the investigational drug but without active ingredients. Up to two nodules will be injected. Depending on the response to the first injection, participants may receive a second injection (treatment 2).

After completing the study, participants will have the option to enroll in an ongoing observational Phase 3 extension study.

Why Take Part?

You may not directly benefit from taking part in EN3835-309 PFI STRIDE, but your participation will help doctors learn about the investigational drug and could help others with PFI in the future.

Length of Study

Once enrolled in the study, participation will last 85 days, regardless of whether participants receive 1 or 2 treatment cycles.

Who Can Join EN3835-309 PFI Stride?

You may be able to join if you:

Other requirements need to be met to join EN3835-309 PFI STRIDE. Please contact us for details.

About Clinical Studies

A clinical research study (also called a clinical trial) is carefully supervised research that is done before an investigational drug becomes available to the public.

  • Clinical studies follow specific rules to protect the rights, safety, well-being, and privacy of participants.
  • The results help investigators decide if an investigational drug is safe and should be made widely available.
  • Clinical studies play an important part in the development of new medical treatments to improve patient care.

Joining EN3835-309 PFI STRIDE is completely up to you. Deciding not to take part will not affect your usual medical care now or in the future. If you take part, you can decide to leave the study at any time and for any reason.

Scroll to Top